TURTLE CAMERON (Chief Executive Officer) received a stock award from SPYRE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/20/2024ACC: 0000950170-24-017494
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+400.00
Net shares
Net buyer
$3.9K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
400.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+400.00
Price / share
$9.82
Trade value
$3.93K
% of position
0.1%
2/15/2024
746.51K→746.91K
Total
Net shares
+400.00
Net value
$3.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2024 | A · Award | +400.00 | $9.82 | $3.93K | 0.1% | 746.51K | 746.91K |
| Total | +400.00 | $3.93K | ||||||
Derivative Transactions0
No derivative transactions reported